News Changchun BCHT Biotechnology Co.

Equities

688276

CNE100005XY6

Pharmaceuticals

End-of-day quote Shanghai S.E. Other stock markets 2026-04-14			5-day change	1st Jan Change
17.86 ^CNY	+1.08%		+0.34%	-5.30%

02-26	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-13	BCHT Biotechnology Gets Nod to Trial Vaccines Against Pertussis, Diphtheria, Tetanus	MT

All News

02-26	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
11-13	BCHT Biotechnology Gets Nod to Trial Vaccines Against Pertussis, Diphtheria, Tetanus	MT
25-10-30	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2025	CI
25-10-09	Changchun High-Tech Unit Gets Approval for Combo Vaccine Trials; Shares Up 5%	MT
25-08-29	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2025	CI
25-06-19	Changchun BCHT Biotechnology Co.(SHSE:688276) dropped from Shanghai Stock Exchange Health Care Sector Index	CI
25-04-20	Changchun BCHT Biotechnology Co. announces Annual dividend, payable on June 18, 2025	CI
25-04-20	Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
25-04-20	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-02-18	Changchun BCHT Biotechnology Deputy General Manager Quits	MT
25-01-29	BCHT Biotechnology to Acquire 33% of Chuanxin Biopharma	MT
24-10-25	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2024	CI
24-08-16	Changchun BCHT Biotechnology H1 Profit Up 24%, Operating Income Rises 11%	MT
24-08-08	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-04-24	Chinese Drug Regulator Accepts BCHT Biotechnology's Marketing Application for Influenza Nasal Spray Vaccine	MT
24-04-19	Changchun BCHT Biotechnology Co. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
24-03-20	Changchun BCHT Biotechnology's 2023 Profit Soars 176% as Revenue Jumps 70%	MT
24-02-26	BCHT Biotechnology's 2023 Profit Surges 176%; Shares Jump 4%	MT
24-02-23	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
23-12-07	BCHT Biotechnology Gets Nod to Trial Rabies Vaccine For Humans	MT
23-12-07	Changchun High-Tech Industry's Unit Gets Nod to Trial Rabies Vaccine	MT
23-10-24	BCHT Biotechnology to Invest 805 Million Yuan in Flu Vaccine Factory	MT
23-10-23	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Nine Months Ended September 30, 2023	CI
23-09-18	Changchun BCHT Biotechnology Co.(XSSC:688276) added to S&P Global BMI Index	CI
23-08-15	Changchun BCHT Biotechnology Co. Reports Earnings Results for the Half Year Ended June 30, 2023	CI